Canada is failing to meet the core principles of the Canada Health Act, leaving many patients without access to life-saving clinical trials, health advocate Louise Binder told the opening session of Research Money's annual conference. She and Independent Senator Colin Deacon from Nova Scotia said by reforming outdated, risk-averse approval systems, the country can translate its world-class research into better health outcomes and economic growth.